Janux Therapeutics Ownership | Who Owns Janux Therapeutics?

Overview Forecast RevenueFinancials Chart

Janux Therapeutics Ownership Summary

Janux Therapeutics is owned by 112.27% institutional investors, 7.23% insiders. Ra capital management is the largest institutional shareholder, holding 18.97% of JANX shares. Fidelity Growth Compy Commingled Pl S is the top mutual fund, with 3.72% of its assets in Janux Therapeutics shares.

JANX Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Janux Therapeutics	112.27%	7.23%	-19.49%
Sector	Healthcare Stocks	57.39%	9.93%	32.68%
Industry	Biotech Stocks	68.48%	9.65%	21.87%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Ra capital management	10.37M	18.97%	$554.98M
Fmr	8.67M	15.87%	$464.19M
Janus henderson group	3.56M	6.52%	$190.62M
Paradigm biocapital advisors lp	3.52M	6.44%	$188.25M
Adage capital partners gp	3.06M	5.60%	$163.93M
Blackrock funding, inc. /de	2.73M	4.99%	$145.94M
Blackrock	2.34M	4.78%	$98.19M
Vanguard group	2.14M	3.91%	$114.38M
Cormorant asset management, lp	2.10M	3.84%	$112.43M
Woodline partners lp	1.85M	3.39%	$99.17M

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Logos global management lp	1.25M	7.83%	$66.92M
Ra capital management	10.37M	7.39%	$554.98M
Paradigm biocapital advisors lp	3.52M	6.55%	$188.25M
Cormorant asset management, lp	2.10M	6.17%	$112.43M
Ally bridge group (ny)	90.29K	4.14%	$4.83M
Avidity partners management lp	741.90K	3.90%	$39.72M
First turn management	383.60K	3.68%	$20.54M
Artia global partners lp	162.98K	3.12%	$8.73M
Ecor1 capital	1.47M	2.98%	$78.69M
Cutter capital management, lp	120.00K	2.63%	$6.42M

Top Buyers

Holder	Shares	% Assets	Change
Ra capital management	10.37M	7.39%	1.20M
Paradigm biocapital advisors lp	3.52M	6.55%	1.12M
Cormorant asset management, lp	2.10M	6.17%	1.05M
Janus henderson group	3.56M	0.10%	1.04M
Holocene advisors, lp	1.02M	0.17%	1.02M

Top Sellers

Holder	Shares	% Assets	Change
Rtw investments, lp	-	-	-1.00M
Orbimed advisors	758.57K	0.84%	-500.00K
Vestal point capital, lp	-	-	-485.00K
Bvf inc/il	-	-	-441.53K
Samlyn capital	-	-	-324.70K

New Positions

Holder	Shares	% Assets	Change	Value
Holocene advisors, lp	1.02M	0.17%	1.02M	$54.35M
Perceptive advisors	817.89K	1.21%	817.89K	$43.79M
Pictet asset management sa	384.80K	0.02%	384.80K	$20.60M
First turn management	383.60K	3.68%	383.60K	$20.54M
First light asset management	313.78K	1.61%	313.78K	$16.80M

Sold Out

Holder	Change
National bank of canada /fi/	-1.00
Capital performance advisors llp	-17.00
Abich financial wealth management	-20.00
Pacer advisors	-439.00
Clear street markets	-700.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Dec 31, 2024	213	29.09%	61,331,550	34.45%	112	1.61%	149	67.42%	37	-22.92%
Sep 30, 2024	164	2.50%	45,609,396	2.07%	83	1.24%	88	-20.00%	48	45.45%
Jun 30, 2024	159	28.23%	44,686,120	5.66%	91	0.99%	109	26.74%	33	17.86%
Mar 31, 2024	124	87.88%	42,293,771	26.24%	96	1.79%	86	109.76%	28	154.55%
Dec 31, 2023	66	11.86%	33,501,724	-4.59%	73	1.04%	41	28.13%	11	-31.25%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Fidelity Growth Compy Commingled Pl S	2.20M	3.72%	268.13K
Fidelity Growth Compy Commingled Pl O	1.65M	3.16%	20.65K
Fidelity Growth Company Fund	1.57M	2.65%	181.58K
Vanguard Total Stock Mkt Idx Inv	1.18M	2.00%	-
Vanguard US Total Market Shares ETF	1.00M	1.69%	193.50K
iShares Russell 2000 ETF	827.22K	1.40%	-7.15K
Fidelity Select Health Care	689.69K	1.17%	25.80K
SPDR® S&P Biotech ETF	689.45K	1.17%	-7.40K
Fidelity Small Cap Growth	655.64K	1.11%	2.70K
Janus Henderson Global Life Sciences	539.05K	0.92%	110.31K

Recent Insider Transactions

Date	Name	Role	Activity	Value
Mar 05, 2025	RA CAPITAL MANAGEMENT, L.P.		Buy	$9.30M
Mar 06, 2025	RA CAPITAL MANAGEMENT, L.P.		Buy	$11.45M
Mar 07, 2025	RA CAPITAL MANAGEMENT, L.P.		Buy	$3.42M
Mar 05, 2025	RA CAPITAL MANAGEMENT, L.P.		Buy	$1.17M
Mar 03, 2025	Meyer Andrew Hollman	Chief Business Officer	Sell	$29.60K

Insider Transactions Trends

Date	Buy	Sell
2025 Q1	4	11
2024 Q4	1	23
2024 Q3	-	33
2024 Q2	-	8
2024 Q1	1	-

JANX Ownership FAQ

Who Owns Janux Therapeutics?

Janux Therapeutics shareholders are primarily institutional investors at 112.27%, followed by 7.23% insiders and -19.50% retail investors. The average institutional ownership in Janux Therapeutics's industry, Biotech Stocks , is 68.48%, which Janux Therapeutics exceeds.

Who owns the most shares of Janux Therapeutics?

Janux Therapeutics’s largest shareholders are Ra capital management (10.37M shares, 18.97%), Fmr (8.67M shares, 15.87%), and Janus henderson group (3.56M shares, 6.52%). Together, they hold 41.37% of Janux Therapeutics’s total shares outstanding.

Does Blackrock own Janux Therapeutics?

Yes, BlackRock owns 4.78% of Janux Therapeutics, totaling 2.34M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 98.19M$. In the last quarter, BlackRock increased its holdings by 650.02K shares, a 38.37% change.

Who is Janux Therapeutics’s biggest shareholder by percentage of total assets invested?

Logos global management lp is Janux Therapeutics’s biggest shareholder by percentage of total assets invested, with 7.83% of its assets in 1.25M Janux Therapeutics shares, valued at 66.92M$.

Who is the top mutual fund holder of Janux Therapeutics shares?

Fidelity Growth Compy Commingled Pl S is the top mutual fund holder of Janux Therapeutics shares, with 3.72% of its total shares outstanding invested in 2.2M Janux Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools